TORONTO, May 05, 2020 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that the Company has entered into a Joint Venture (the “JV”) with QualCann SAS (“QualCann”), an arm’s length third party, to produce extract oil to be commercialized in the United States of America (“US”) market.